{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:38:32Z","timestamp":1775083112113,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/ja.2017.99","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T09:42:52Z","timestamp":1504690972000},"page":"1078-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Structures and biological activities of novel 4\u2019-acetylated analogs of chrysomycins A and B"],"prefix":"10.1038","volume":"70","author":[{"given":"Shun-ichi","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiki","family":"Iwanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Nagayoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chigusa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"BFja201799_CR1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.7164\/antibiotics.35.1194","volume":"35","author":"U Weiss","year":"1982","unstructured":"Weiss, U. et al. The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A. J. Antibiot. 35, 1194\u20131201 (1982).","journal-title":"J. Antibiot."},{"key":"BFja201799_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7164\/antibiotics.34.271","volume":"34","author":"K Takahashi","year":"1981","unstructured":"Takahashi, K., Yoshida, M., Tomita, F. & Shirahata, K. Gilvocarcins, new antitumor antibiotics. 2. Structural elucidation. J. Antibiot. 34, 271\u2013275 (1981).","journal-title":"J. Antibiot."},{"key":"BFja201799_CR3","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1139\/v81-438","volume":"59","author":"JA Findlay","year":"1981","unstructured":"Findlay, J. A., Liu, J. S., Radics, L. & Rakhit, S. The structure of ravidomycin. Can. J. Chem 59, 3018\u20133020 (1981).","journal-title":"Can. J. Chem"},{"key":"BFja201799_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1139\/v83-058","volume":"61","author":"JA Findlay","year":"1983","unstructured":"Findlay, J. A., Liu, J. S. & Radics, L. On the structure, chemistry, and C-13 nuclear magnetic-resonance of ravidomycin. Can. J. Chem. 61, 323\u2013327 (1983).","journal-title":"Can. J. Chem."},{"key":"BFja201799_CR5","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1039\/b808633h","volume":"6","author":"YQ Li","year":"2008","unstructured":"Li, Y. Q. et al. Plasticity in gilvocarcin-type C-glycoside pathways: discovery and antitumoral evaluation of polycarcin V from Streptomyces polyformus. Org. Biomol. Chem. 6, 3601\u20133605 (2008).","journal-title":"Org. Biomol. Chem."},{"key":"BFja201799_CR6","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7164\/antibiotics.42.1446","volume":"42","author":"JA Matson","year":"1989","unstructured":"Matson, J. A. et al. Antitumor activity of chrysomycins M and V. J. Antibiot. 42, 1446\u20131448 (1989).","journal-title":"J. Antibiot."},{"key":"BFja201799_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.7164\/antibiotics.34.266","volume":"34","author":"H Nakano","year":"1981","unstructured":"Nakano, H. et al. Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities. J. Antibiot. 34, 266\u2013270 (1981).","journal-title":"J. Antibiot."},{"key":"BFja201799_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.7164\/antibiotics.34.701","volume":"34","author":"M Morimoto","year":"1981","unstructured":"Morimoto, M., Okubo, S., Tomita, F. & Marumo, H. Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity. J. Antibiot. 34, 701\u2013707 (1981).","journal-title":"J. Antibiot."},{"key":"BFja201799_CR9","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/0959-8049(93)90459-S","volume":"29A","author":"A Lorico","year":"1993","unstructured":"Lorico, A. & Long, B. H. Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II. Eur. J. Cancer 29A, 1985\u20131991 (1993).","journal-title":"Eur. J. Cancer"},{"key":"BFja201799_CR10","first-page":"3921","volume":"60","author":"A Matsumoto","year":"2000","unstructured":"Matsumoto, A. & Hanawalt, P. C. Histone H3 and heat shock protein GRP78 are selectively cross-linked to DNA by photoactivated gilvocarcin V in human fibroblasts. Cancer Res. 60, 3921\u20133926 (2000).","journal-title":"Cancer Res."},{"key":"BFja201799_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF00873046","volume":"12","author":"G Goss","year":"1994","unstructured":"Goss, G. et al. Phase II study of elsamitrucin in non-small cell lung cancer. Invest. New Drugs 12, 315\u2013317 (1994).","journal-title":"Invest. New Drugs"},{"key":"BFja201799_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00210793","volume":"14","author":"SL Allen","year":"1996","unstructured":"Allen, S. L. et al. Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory\/relapsed non-Hodgkin's lymphoma. Invest. New Drugs 14, 213\u2013217 (1996).","journal-title":"Invest. New Drugs"},{"key":"BFja201799_CR13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/jb.69.3.280-283.1955","volume":"69","author":"F Strelitz","year":"1955","unstructured":"Strelitz, F., Flon, H. & Acheshov, I. N. Chrysomycin: a new antibiotic substance for bacterial viruses. J. Bacteriol. 69, 280\u2013283 (1955).","journal-title":"J. Bacteriol."},{"key":"BFja201799_CR14","first-page":"963","volume":"22","author":"GF Gauze","year":"1977","unstructured":"Gauze, G. F. et al. Formation of new antibiotic, virenomycin, by a culture of Streptomyces virens sp. nev. Antibiotiki. 22, 963\u2013967 (1977).","journal-title":"Antibiotiki."},{"key":"BFja201799_CR15","first-page":"967","volume":"22","author":"MG Brazhnikova","year":"1977","unstructured":"Brazhnikova, M. G. et al. Physico-chemical characteristics of the new antitumor antibiotic virenomycin. Antibiotiki. 22, 967\u2013970 (1977).","journal-title":"Antibiotiki."},{"key":"BFja201799_CR16","first-page":"507","volume":"27","author":"MK Kudinova","year":"1982","unstructured":"Kudinova, M. K. et al. Separation and characteristics of the components of the antibiotic virenomycin. Antibiotiki. 27, 507\u2013511 (1982).","journal-title":"Antibiotiki."},{"key":"BFja201799_CR17","first-page":"884","volume":"29","author":"MG Brazhnikova","year":"1984","unstructured":"Brazhnikova, M. G. et al. Structure of the antibiotic virenomycin. Antibiotiki. 29, 884\u2013892 (1984).","journal-title":"Antibiotiki."},{"key":"BFja201799_CR18","doi-asserted-by":"publisher","first-page":"21046","DOI":"10.1039\/c3ra42884b","volume":"3","author":"SK Jain","year":"2013","unstructured":"Jain, S. K. et al. Chrysomycins A-C, antileukemic naphthocoumarins from Streptomyces sporoverrucosus. RSC Adv. 3, 21046\u201321053 (2013).","journal-title":"RSC Adv."},{"key":"BFja201799_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbrc.2008.11.059","volume":"378","author":"N Ashley","year":"2009","unstructured":"Ashley, N. & Poulton, J. Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs. Biochem. Biophys. Res. Commun. 378, 450\u2013455 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFja201799_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7164\/antibiotics.35.545","volume":"35","author":"TT Wei","year":"1982","unstructured":"Wei, T. T., Byrne, K. M., Warnick-Pickle, D. & Greenstein, M. Studies on the mechanism of actin of gilvocarcin V and chrysomycin A. J. Antibiot. 35, 545\u2013548 (1982).","journal-title":"J. Antibiot."}],"updated-by":[{"DOI":"10.1038\/ja.2017.128","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000}}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja201799.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja201799","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ja.2017.99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ja201799.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:19:32Z","timestamp":1641003572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFja201799"],"URL":"https:\/\/doi.org\/10.1038\/ja.2017.99","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]},"assertion":[{"value":"31 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}